6gbt
From Proteopedia
(Difference between revisions)
(New page: '''Unreleased structure''' The entry 6gbt is ON HOLD Authors: Badran, M., Klebe, G., Heine, A., Marchais-Oberwinkler, S. Description: 17beta-hydroxysteroid dehydrogenase type 14 Mutant...) |
|||
| (2 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==17beta-hydroxysteroid dehydrogenase type 14 Mutant Y253A in complex with a non-steroidal inhibitor== | |
| - | + | <StructureSection load='6gbt' size='340' side='right'caption='[[6gbt]], [[Resolution|resolution]] 2.10Å' scene=''> | |
| - | + | == Structural highlights == | |
| - | + | <table><tr><td colspan='2'>[[6gbt]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6GBT OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6GBT FirstGlance]. <br> | |
| - | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=DMS:DIMETHYL+SULFOXIDE'>DMS</scene>, <scene name='pdbligand=F45:[6-(3,4-DIHYDROXYPHENYL)PYRIDIN-2-YL](4-FLUORO-3-HYDROXYPHENYL)METHANONE'>F45</scene>, <scene name='pdbligand=NA:SODIUM+ION'>NA</scene>, <scene name='pdbligand=NAD:NICOTINAMIDE-ADENINE-DINUCLEOTIDE'>NAD</scene></td></tr> | |
| - | [[Category: | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6gbt FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6gbt OCA], [http://pdbe.org/6gbt PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6gbt RCSB], [http://www.ebi.ac.uk/pdbsum/6gbt PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6gbt ProSAT]</span></td></tr> |
| + | </table> | ||
| + | == Function == | ||
| + | [[http://www.uniprot.org/uniprot/DHB14_HUMAN DHB14_HUMAN]] Has NAD-dependent 17-beta-hydroxysteroid dehydrogenase activity. Converts oestradiol to oestrone. The physiological substrate is not known. Acts on oestradiol and 5-androstene-3-beta,17-beta-diol (in vitro).<ref>PMID:17067289</ref> | ||
| + | == References == | ||
| + | <references/> | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Large Structures]] | ||
| + | [[Category: Badran, M]] | ||
[[Category: Heine, A]] | [[Category: Heine, A]] | ||
| - | [[Category: | + | [[Category: Klebe, G]] |
[[Category: Marchais-Oberwinkler, S]] | [[Category: Marchais-Oberwinkler, S]] | ||
| - | [[Category: | + | [[Category: Inhibitor complex mutant]] |
| + | [[Category: Oxidoreductase]] | ||
Current revision
17beta-hydroxysteroid dehydrogenase type 14 Mutant Y253A in complex with a non-steroidal inhibitor
| |||||||||||
